Randomized Clinical Trial to Evaluate Safety, Tolerability and PK-PD Profile of Metformin Glycinate 620 mg,1240 mg, 2480 mg and Metformin Chlorhydrate 1000 mg of One Single Dose, Multiple Dose and After Food Intake.
Phase of Trial: Phase I
Latest Information Update: 01 Feb 2018
At a glance
- Drugs Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Laboratorios Silanes
- 13 Feb 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 27 Mar 2012 New trial record